Visioneering Technologies (VTI) Stock Price, News & Analysis

Company Overview

Visioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of contact lenses in North America, Europe, and the Asia-Pacific. Its flagship product is NaturalVue, a multifocal one-day contact lens for adults with presbyopia and children with myopia. The company was incorporated in 2008 and is headquartered in Alpharetta, Georgia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: A$2.29 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: ASX:VTI
• CIK: N/A
• Web: www.vtivision.com
• Phone: 844-884-5367
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): A($0.11)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -A$3.48 million
• Net Margins: -41.41%
• Pretax Margin: N/A
• Return on Equity: -42.77%
• Return on Assets: -34.52%

Debt

• Debt-to-Equity Ratio: 3.98
• Current Ratio: 3.38
• Quick Ratio: 4.82

Sales & Book Value

• Annual Sales: A$8.64 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: A$0.12 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 56,130,000
• Free Float: N/A
• Market Cap: A$2.29 million
• Optionable: Not Optionable
• Beta: 1.77